CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- PositionProfit margin is -99.7%, lower than 95% of its Health Information Services peers (median -1.8%)
- FinancialsAltman Z-Score -2.55: distress zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
492.47MUSDvs all stocks (USD)
Revenue (TTM)
81.18MUSDvs all stocks (USD)
Profit Margin
-99.70%vs Health Information Services peers
Beta
0.9580xvs all stocks
52-Week Change
68.19%vs all stocks
Market Capitalization
492.47MUSDvs all stocks (USD)
Enterprise Value
418.44MUSDvs all stocks (USD)
Forward P/E
-10.48xvs Health Information Services peers
Price to Sales (TTM)
6.07xvs Health Information Services peers
Price to Book (MRQ)
9.23xvs Health Information Services peers
Enterprise to Revenue
5.16xvs Health Information Services peers
Enterprise to EBITDA
-5.95xvs Health Information Services peers
Gross Margin
68.01%vs Health Information Services peers
Profit Margin
-99.70%vs Health Information Services peers
Operating Margin
-79.69%vs Health Information Services peers
Return on Assets (TTM)
-29.71%vs Health Information Services peers
Return on Equity (TTM)
-123.28%vs Health Information Services peers
Revenue (TTM)
81.18MUSDvs all stocks (USD)
Revenue per Share (TTM)
1.18USDUpdated Jul 19, 2026Quarterly Revenue Growth
22.00%vs Health Information Services peers
Gross Profit (TTM)
54.62MUSDvs all stocks (USD)
EBITDA (TTM)
-70.32MUSDvs all stocks (USD)
Net Income (TTM)
-80.94MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
21.99%vs Health Information Services peers
Operating Cash Flow (TTM)
-40.26MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-24.59MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Health Information Services peers
Revenue
77.27MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
25.19MUSDFY2025 · Dec 31, 2025Gross Profit
52.08MUSDFY2025 · Dec 31, 2025Operating Income
-70.91MUSDvs all stocks (USD)
Pre-tax Income
-77.49MUSDFY2025 · Dec 31, 2025Income Tax Expense
1.51MUSDFY2025 · Dec 31, 2025Net Income
-79.00MUSDFY2025 · Dec 31, 2025EBIT
-72.93MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-59.51MUSDFY2025 · Dec 31, 2025Research & Development
34.22MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
86.07MUSDFY2025 · Dec 31, 2025Other Operating Expenses
86.00KUSDFY2025 · Dec 31, 2025Non-operating Interest Income
1.87MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
4.55MUSDFY2025 · Dec 31, 2025EPS (Basic)
-1.17USDFY2025 · Dec 31, 2025EPS (Diluted)
-1.17USDFY2025 · Dec 31, 2025Basic Shares Outstanding
67.54MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
67.54MSharesFY2025 · Dec 31, 2025Operating Cash Flow
-37.23MUSDFY2025 · Dec 31, 2025Free Cash Flow
-37.80MUSDDerived from operating cash flow minus capital expenditure. This filing charges 9.53M of depreciation against 574K of capital expenditure, and its own free-cash-flow line reads -44.51M.FY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
70.29MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-77.49MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
9.53MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-977.00KUSDFY2025 · Dec 31, 2025Stock-based Compensation
16.20MUSDFY2025 · Dec 31, 2025Other Non-cash Items
5.13MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-6.60MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
16.93MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
46.00KUSDFY2025 · Dec 31, 2025Capital Expenditures
-574.00KUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-108.00KUSDFY2025 · Dec 31, 2025Net Acquisitions
-1.89MUSDFY2025 · Dec 31, 2025Sale of Investments
0.00USDFY2025 · Dec 31, 2025Net Investing Cash Flow
-2.46MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
34.56MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-1.87MUSDFY2025 · Dec 31, 2025Common Dividends Paid
0.00USDFY2025 · Dec 31, 2025Net Financing Cash Flow
33.78MUSDFY2025 · Dec 31, 2025Shares Outstanding
71.79MSharesUpdated Jul 19, 2026Float Shares
54.70MSharesUpdated Jul 19, 2026Shares Short
636.13KSharesUpdated Jul 19, 2026Short Ratio
2.13daysvs all stocks
Short % of Shares Outstanding
0.81%vs all stocks
% Held by Insiders
7.08%vs all stocks
% Held by Institutions
48.04%vs all stocks
Total Cash (MRQ)
65.39MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.9110USDUpdated Jul 19, 2026Total Debt (MRQ)
62.42MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
1.37xvs Health Information Services peers
Current Ratio (MRQ)
2.06xvs Health Information Services peers
Book Value per Share (MRQ)
0.6360USDUpdated Jul 19, 2026Total Assets
163.03MUSDvs all stocks (USD)
Total Current Assets
99.08MUSDFY2025 · Dec 31, 2025Total Liabilities
115.89MUSDFY2025 · Dec 31, 2025Total Non-current Assets
63.95MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
65.36MUSDFY2025 · Dec 31, 2025Total Current Liabilities
50.53MUSDFY2025 · Dec 31, 2025Cash
37.46MUSDFY2025 · Dec 31, 2025Cash Equivalents
32.83MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
70.29MUSDFY2025 · Dec 31, 2025Accounts Receivable
14.40MUSDFY2025 · Dec 31, 2025Inventory
6.35MUSDFY2025 · Dec 31, 2025Accounts Payable
5.32MUSDFY2025 · Dec 31, 2025Short-term Debt
2.70MUSDFY2025 · Dec 31, 2025Deferred Revenue
16.72MUSDFY2025 · Dec 31, 2025Other Current Liabilities
1.41MUSDFY2025 · Dec 31, 2025Long-term Debt
60.32MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
876.00KUSDFY2025 · Dec 31, 2025Common Stock (Book)
4.81MUSDFY2025 · Dec 31, 2025Retained Earnings
-519.28MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
47.15MUSDvs all stocks (USD)
Treasury Stock
1.22MUSDFY2025 · Dec 31, 202552-Week Low
2.92USDUpdated Jul 19, 202652-Week High
6.30USDUpdated Jul 19, 202652-Week Change
68.19%vs all stocks
Beta
0.9580xvs all stocks
50-Day MA
5.23USDUpdated Jul 19, 2026200-Day MA
4.87USDUpdated Jul 19, 2026Avg 10-Day Volume
304.15KSharesUpdated Jul 19, 2026Avg 30-Day Volume
333.54KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
-1.18USDUpdated Jul 19, 2026Other Income / Expense
-3.90MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Diagnostic
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is -99.7%, lower than 95% of its Health Information Services peers (median -1.8%)Significant
Profit margin: -1.00Industry median: -0.02Industry P5: -0.91Peers compared: 33.00
Return on equity is -123.3%, lower than 95% of its Health Information Services peers (median 0.5%)Significant
Return on equity: -1.23Industry median: 0.01Industry P5: -1.03Peers compared: 33.00
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.68Profit Margin: -1.00
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 2.06Altman Z-Score: -2.55
Financial Health
Altman Z-Score -2.55: distress zoneCritical
Altman Z-Score: -2.55
Low earnings qualitySignificant
Earnings Quality Score: -0.56
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Companies that share the same coordination system — how they create, deliver, or capture value.
National Research Corporation
Tier 1SenseMakingRecurring-Revenue Lock-InInterfaceFlow
Bairong Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InInterfaceProduction
Beijing Dataway Horizon Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InFlowInterface
Computer Engineer & Consulting Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionInterface
Bonree Data Technology Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionFlow
Japan Business Systems Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InFlowProduction
Xinjiang Sailing Information Technology Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionFlow
Lunit Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionInterface
Business Engineering Corp.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionInterface
CI&T Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Immunome Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Iovance Biotherapeutics, Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Twist Bioscience Corporation
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC